Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.025
-0.015 (-1.44%)
At close: Sep 29, 2026
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $2.78 million as of September 29, 2026. Its market cap has increased by 40.54% in one year.
Market Cap
2.78M
Enterprise Value
3.37M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.03
ChartMarket Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.78M, a decrease of -97.87%. That is a compound annual growth rate of -37.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 2.78M | -3.30% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacific Software | 3.75M |
| Eastgate Biotech | 2.86M |
| International Stem Cell | 2.77M |
| CASI Pharmaceuticals | 2.65M |
| GPL Holdings | 2.56M |
| BioAtla | 2.47M |
| Bioxytran | 2.42M |
| Abpro Holdings | 2.42M |